Clinical Trial

Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
Unable to recruit
Summary
This study at UCLA Center for Health Sciences is testing whether the Autoimmune Protocol (AIP) diet can lower protein levels in the urine of people with IgA Nephropathy (IgAN), a common kidney disease that can lead to kidney failure. The AIP diet avoids foods that may cause inflammation (like dairy, grains, and sugar) for 8 weeks, then gradually reintroduces them over 4 months. We're enrolling 30 adults aged 18-65 with IgAN and protein in their urine to try this diet for 6 months. Participants will track their urine protein daily at home, keep a food log, and have monthly lab checkups, with support from a diet expert. The main goal is to see if the diet reduces urine protein by 20% or more, which could slow disease progression and reduce the need for treatments like dialysis. This exploratory study aims to find out if diet changes can help manage IgAN.
Protocol Amendment History 3 changes
critical Withdrawn before enrolling 2026-07-28
critical Trial withdrawn: Unable to recruit 2026-07-28
notable Enrollment reduced: 30 -> 0 participants 2026-07-28
Trial Details
NCT Number NCT07022574
Lead Sponsor University of California, Los Angeles
Conditions IgA Nephropathy (IgAN)
Start Date 2026-02-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-27